### 10857 Federal Register / Vol. 81, No. 41 / Wednesday, March 2, 2016 / Notices

collection of information is necessary for the proper performance of the functions of the Agency, including whether the information will have practical utility; (ii) evaluate the accuracy of the Agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (iii) enhance the quality, utility, and clarity of the information to be collected; and (iv) minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated electronic, mechanical, or other technological collection techniques or other forms of information technology,
e.g., permitting electronic submission of responses. EPA will consider the comments received and amend the ICR as appropriate. The final ICR package will then be submitted to OMB for review and approval. At that time, EPA will issue another Federal Register notice to announce the submission of the ICR to OMB and the opportunity to submit additional comments to OMB.

Abstract: EPA’s Office of Land and Emergency Management Sustainable Food Management (SFM) program is designed to advance sustainable food management practices throughout the United States by preventing and diverting wasted food from landfills. The focal point of the SFM program is the Food Recovery Challenge in which organizations pledge to improve their sustainable food management practices. The success of the SFM program efforts to divert wasted food from landfills requires sufficient capacity to process the diverted materials which includes composting and anaerobic digestion operations. In addition to increasing opportunity to process wasted food diverted from the municipal solid waste stream, anaerobic digesters achieve social, environmental and economic benefits, such as generation of renewable energy, reduction of methane emissions, and opportunities to improve soil health through the production of soil amendments. The SFM program supports these efforts by educating state and local governments and communities about the benefits of wasted food diversion. The SFM program also builds partnerships with state agencies and other strategic partners interested in developing organics recycling capacity and provides tools to assist organizations in developing anaerobic digestion (AD) projects.

This information collection consists of a request for data not currently available on AD facilities processing wasted food as well as a review and update of the existing SFM AD facility inventory. Correspondence will include a questionnaire through which respondents can provide new information on their AD projects and an update to the existing AD facility inventory, if appropriate. This will be the first time the SFM program has formally collected data for this inventory.

Form numbers: None. Respondents/affected entities: State Liaisons, Industry Representatives, Project Owner/Operators, and Other Stakeholders ( e.g. non-profits).

Respondent’s obligation to respond: Voluntary.

Estimated number of respondents: 460 (total).

Frequency of response: Annually. Total estimated burden: 231 hours (per year). Burden is defined at 5 CFR 1320.03(b).

Total estimated cost: $16,972 (per year), includes $0 annualized capital or operation & maintenance costs.

Changes in estimates: There are no changes in burden estimates as this is a new ICR.

Dated: February 18, 2016. John A. Armstead, Director, Land and Chemicals Division, EPA Region III.
[FR Doc. 2016–04603 Filed 3–1–16; 8:45 am]

**BILLING CODE 6560–50–P**

**ENVIRONMENTAL PROTECTION AGENCY** 

**[EPA–HQ–OPPT–2016–0099; FRL–9942–65]**

**Premanufacture Notice for a Certain New Chemical; Extension of Review**  **Period**

**AGENCY :**  Environmental Protection Agency (EPA).

**ACTION :**  Notice.

**SUMMARY :**  This notice announces EPA’s extension of the review period for a premanufacture notice (PMN) P–14– 0627 under the Toxic Substances Control Act (TSCA). Based on analysis, the Agency requires an extension of the review period to investigate further potential risk, examine regulatory options, and prepare the necessary documents, should regulatory action be required.

**DATES :**  The review period is extended to May 25, 2016.

**FOR FURTHER INFORMATION CONTACT :** 

For technical information contact: Jeff Bauer, Chemical Control Division (7405M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460–0001; telephone number: (202) 564–9042; email address: Bauer.Jeff@epa.gov.

For general information contact: The TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554– 1404; email address: TSCA-Hotline@
epa.gov.

**SUPPLEMENTARY INFORMATION :** 
I. General Information A. Does this action apply to me?

This action is directed to the chemical manufacturing company that submitted the PMN. This action may also be of interest to persons concerned about health, environmental, and/or economic aspects of this new chemical substance. Since other entities may also be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. B. How can I get copies of this document and other related information?

The docket for this action, identified by docket identification (ID) number EPA–HQ–OPPT–2016–0099, is available
at http://www.regulations.gov or at the Office of Pollution Prevention and Toxics Docket (OPPT Docket), Environmental Protection Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301 Constitution Ave. NW., Washington, DC. The Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is (202) 566–1744, and the telephone number for the OPPT Docket is (202) 566–0280. Please review the visitor instructions and additional information about the docket available
at http://www.epa.gov/dockets. II. What chemical is subject to this notice?

On June 19, 2014, EPA received PMN number P–14–0627 for a new chemical substance, identified as Cyclic amide. The submitter claimed the company name, specific chemical identity, production volume, use information, process information, and other information to be CBI. III. What action is the Agency taking?

The notice of receipt for this PMN was published in the Federal Register of September 16, 2014 (79 FR 55460) (FRL–9915–80). The running of the PMN review period was voluntarily suspended by the PMN submitter with EPA’s agreement. The PMN review period has been resumed. As extended,


### 10858 Federal Register / Vol. 81, No. 41 / Wednesday, March 2, 2016 / Notices

the review period for this PMN expires May 25, 2016. IV. What is EPA’s authority for taking this action?

Section 5(c) of TSCA and 40 CFR 720.75(c) authorizes EPA to extend, for good cause, the 90-day PMN review period for additional periods not to exceed in the aggregate 90 days. For this PMN, EPA finds that there is good cause to extend the review period. Based on analysis, EPA may need to regulate this new chemical substance and the Agency needs an extension of the review period to further investigate potential risk, examine regulatory options, and prepare the necessary documents, should regulatory action be required.

Authority: 15 U.S.C. 2601 et seq. Dated: February 25, 2016. Greg Schweer, Chief, New Chemicals Notice Management Branch, Office of Pollution Prevention and Toxics.
[FR Doc. 2016–04597 Filed 3–1–16; 8:45 am]

**BILLING CODE 6560–50–P**

**ENVIRONMENTAL PROTECTION AGENCY** 

**[FDA–2015–N–3403; FRL–9943–08]**

**Modernizing the Regulatory System for Biotechnology Products; Notice of**  **Second Public Meeting**

**AGENCY :**  Environmental Protection Agency (EPA).

**ACTION :**  Notice.

**SUMMARY :**  Under the auspices of the National Science and Technology Council, EPA, along with the Office of Science and Technology Policy (OSTP), the Food and Drug Administration (FDA), and the United States Department of Agriculture (USDA) are holding a second public meeting related to the memorandum entitled, ‘‘Modernizing the Regulatory System for Biotechnology Products,’’ issued by the Executive Office of the President (EOP) in July 2015. The purpose of the second public meeting is to illustrate current federal roles and responsibilities regarding biotechnology products. The docket, FDA–2015–N–3403, established by FDA prior to the first public meeting will continue to be used for this interagency effort.

**DATES :**  The meeting will be held on March 9, 2016, from 9:30 a.m. to 1:00
p.m.

To request accommodation of a disability, please immediately contact the person listed under **FOR FURTHER**
**INFORMATON CONTACT** to give EPA as much time as possible to process your request.

**ADDRESSES :**  The meeting will be held at the EPA Region 6 Office at 1445 Ross Avenue, Dallas, Texas 75202–2750.

**FOR FURTHER INFORMATION CONTACT :**  For general questions about the meeting, contact Robert McNally, Biopesticides and Pollution Prevention Division (7511P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460–0001; main telephone number: (703) 305–7090; email address: BPPDFRNotices@epa.gov. For questions about the memorandum entitled, ‘‘Modernizing the Regulatory System for Biotechnology Products,’’ or related activities described in that memorandum, contact the National Science and Technology Council: Emerging Technologies Interagency Policy Coordination Committee, Office of Science and Technology Policy, Executive Office of the President, Eisenhower Executive Office Building, 1650 Pennsylvania Ave. Washington, DC 20504, 202–456–4444, online: https://www.whitehouse.gov/webform/contact-emerging-technologiesinteragency-policy-coordinatingcommittee-national-science-and.

**SUPPLEMENTARY INFORMATION :**  I. Background

Under the auspices of the National Science and Technology Council, EPA, FDA, USDA and OSTP (collectively referred to as ‘‘we’’ in this Federal Register document), held a public meeting on October 30, 2015, to discuss the Executive Office of the President (EOP) memorandum entitled, ‘‘Modernizing the Regulatory System for Biotechnology Products,’’ that was issued in July 2015. The purpose of the October 2015 meeting was to inform the public about the activities described in the July 2015 memorandum; invite oral comments from interested parties; and provide information about how to submit written comments, data, or other information to the docket. The October meeting was the first of three public engagement sessions on this topic.

On February 1, 2016, we announced the dates and locations for the second and third public engagement sessions: (1) https://wcms.epa.gov/pesticides/save-date-march-9-30-2016-publicmeetings-updating-coordinatedframework-regulation; (2) http:// www.fda.gov/NewsEvents/ MeetingsConferencesWorkshops/ ucm463783.htm; and (3) https:// www.aphis.usda.gov/aphis/ourfocus/ biotechnology/sa

_stakeholder

_ meetings/cf

_meeting. The second public meeting will be held on March 9, 2016, from 9:30 a.m. to 1:00 p.m. at EPA’s Region 6 Office in Dallas, Texas. The second public meeting will be used to illustrate current federal roles and responsibilities regarding biotechnology products. The final meeting agenda will be placed in the docket [FDA–2015–N–3403] as soon as it is available.

The third public meeting will be held on March 30, 2016, at the University of California’s Davis Conference Center in Davis, California and information about that meeting, including an agenda and information regarding how to register will be placed in the docket and on the USDA Web site prior to the meeting.
II. How can I participate in the March 9th meeting?

To participate in person or by webinar via Adobe Connect, please register online at http://www.epa.gov/regulation-biotechnology-under-tscaand-fifra/modernizing-regulatorysystem-biotechnology-products.

Those registered will receive detailed instructions with their confirmations that explain how to access the meeting via webinar or in person.
III. Meeting Materials, Transcripts and Recorded Video

Any additional information and data submitted voluntarily to us will become part of the administrative record for this activity and will be accessible to the public in the docket [FDA–2015–N– 3403] at http://www.regulations.gov. The transcript of the proceedings from the public meeting will become part of the administrative record for this activity and will also be included in the docket. Please be advised that as soon as a transcript is available, it will be accessible in the docket at http:// www.regulations.gov.

Transcripts and meeting materials may also be viewed at the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. A transcript will be available in either hardcopy or on CD–ROM, after submission of a Freedom of Information request. Written requests are to be sent to the FDA Division of Freedom of Information, 5630 Fishers Lane, Rm. 1035, Rockville, MD 20857. Additionally, we will live webcast and record the public meeting. Once the recorded video is available, it will be accessible on EPA’s YouTube Channel.